Non-ischemic neurological manifestations in patients with primary antiphospholipid syndrome

被引:0
作者
Kalashnikova, LA [1 ]
机构
[1] Russian Acad Med Sci, Sci Res Inst Neurol, Moscow, Russia
来源
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2005年 / 105卷 / 02期
关键词
antiphospholipid antibodies; primary antiphospholipid syndrome; non-ischemic neurological manifestations;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Ischemic disorders of brain blood circulation caused by brain artery thrombosis due to antiphospholipids-induced anticoagulopathy are main neurological appearances of primary antiphospholipid syndrome (PAPS). A number of neurological disorders in patients with PAPS are the result of primary involvement of the brain and peripheral nervous system. We analyzed the spectrum of neurological non-ischemic PAPS manifestations in 125 patients (102 female, 23 male, mean age - 37.5 +/- 11.3 years) with definite PAPS. These manifestations included headache (67%), epileptic seizures (23%), chorea (15%), optic neuropathy (9%), peripheral neuropathy (6%), multiple sclerosis like syndrome (MSLS) (8%), acute psychosis (2%), myasthenic syndrome (1%), non-vascular parkinsonism (1%). In the development of non-ischemic RAPS manifestations, antiphospholipids as well as other antibodies produced as a result of immune disregulation (antibodies to acetylcholine receptors in myasthenic syndrome, antineuronal antibodies in MSLS) may have pathogenic significance. In some cases a role of infection involved in PAPS manifestation cannot be ruled out.
引用
收藏
页码:18 / 23
页数:6
相关论文
共 50 条
  • [41] SNEDDONS SYNDROME AND THE PRIMARY ANTIPHOSPHOLIPID SYNDROME
    KALASHNIKOVA, LA
    NASONOV, EL
    STOYANOVICH, LZ
    KOVALYOV, VU
    KOSHELEVA, NM
    RESHETNYAK, TM
    [J]. CEREBROVASCULAR DISEASES, 1994, 4 (02) : 76 - 82
  • [42] Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository
    Lopes, Erivelton de Azevedo
    Moreira Balbi, Gustavo Guimaraes
    Tektonidou, Maria G.
    Pengo, Vittorio
    Sciascia, Savino
    Ugarte, Amaia
    Belmont, H. Michael
    Gerosa, Maria
    Fortin, Paul R.
    Lopez-Pedrera, Chary
    Ji, Lanlan
    Cohen, Hannah
    de Jesus, Guilherme Ramires
    Branch, D. Ware
    Nalli, Cecilia
    Petri, Michelle
    Rodriguez, Esther
    Kello, Nina
    Rios-Garces, Roberto
    Knight, Jason S.
    Atsumi, Tatsuya
    Willis, Rohan
    Bertolaccini, Maria Laura
    Erkan, Doruk
    Andrade, Danieli
    [J]. ADVANCES IN RHEUMATOLOGY, 2021, 61 (01)
  • [43] Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository
    Erivelton de Azevedo Lopes
    Gustavo Guimarães Moreira Balbi
    Maria G. Tektonidou
    Vittorio Pengo
    Savino Sciascia
    Amaia Ugarte
    H. Michael Belmont
    Maria Gerosa
    Paul R. Fortin
    Chary Lopez-Pedrera
    Lanlan Ji
    Hannah Cohen
    Guilherme Ramires de Jesús
    D. Ware Branch
    Cecilia Nalli
    Michelle Petri
    Esther Rodriguez
    Nina Kello
    Roberto Ríos-Garcés
    Jason S. Knight
    Tatsuya Atsumi
    Rohan Willis
    Maria Laura Bertolaccini
    Doruk Erkan
    Danieli Andrade
    [J]. Advances in Rheumatology, 61
  • [44] Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestations of antiphospholipid syndrome.: A prospective study
    De Bandt, M
    Benali, K
    Guillevin, L
    Hachulla, E
    Job, C
    Fautrel, B
    Fournié, G
    Bonnet, C
    Fournié, B
    Le Goff, P
    Jorgensen, C
    Meyer, O
    [J]. JOURNAL OF RHEUMATOLOGY, 1999, 26 (01) : 91 - 96
  • [45] THE DEVASTATING PRIMARY ANTIPHOSPHOLIPID SYNDROME
    ARENAS, MD
    RIVERA, F
    ALBERO, MD
    TORRALBA, J
    FRANCO, A
    MARCO, P
    OLIVARES, J
    [J]. NEFROLOGIA, 1995, 15 (04): : 375 - 378
  • [46] Cardiac manifestations in primary antiphospholipid syndrome and their association to antiphospholipid antibodies' types and titers-cross-sectional study of Serbian cohort
    Djokovic, Aleksandra
    Stojanovich, Ljudmila
    Stanisavljevic, Natasa
    Djokic, Sandra
    Filipovic, Branka
    Matic, Predrag
    Milanovic, Milomir
    Apostolovic, Svetlana
    Saponjski, Jovica
    [J]. CLINICAL RHEUMATOLOGY, 2022, 41 (05) : 1447 - 1455
  • [47] Cardiac manifestations in primary antiphospholipid syndrome and their association to antiphospholipid antibodies’ types and titers—cross-sectional study of Serbian cohort
    Aleksandra Djokovic
    Ljudmila Stojanovich
    Natasa Stanisavljevic
    Sandra Djokic
    Branka Filipovic
    Predrag Matic
    Milomir Milanovic
    Svetlana Apostolovic
    Jovica Saponjski
    [J]. Clinical Rheumatology, 2022, 41 : 1447 - 1455
  • [48] Antiphospholipid antibodies in patients with antiphospholipid syndrome
    Dodig, Slavica
    Cepelak, Ivana
    [J]. BIOCHEMIA MEDICA, 2024, 34 (02)
  • [49] Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations
    Cervera, R.
    Tektonidou, M. G.
    Espinosa, G.
    Cabral, A. R.
    Gonzalez, E. B.
    Erkan, D.
    Vadya, S.
    Adrogue, H. E.
    Solomon, M.
    Zandman-Goddard, G.
    Shoenfeld, Y.
    [J]. LUPUS, 2011, 20 (02) : 174 - 181
  • [50] Primary antiphospholipid syndrome in Latin American mestizo patients:: clinical and immunologic characteristics and comparison with European patients
    Mejia-Romero, Rossana
    Garcia-Carrasco, Mario
    Galarza-Maldonado, Claudio
    Santos, Pedro
    Mendoza-Pinto, Claudia
    Escarcega, Ricardo O.
    Salinas-Saldivar, Salvador
    Soto-Vega, Elena
    Lopez-Colombo, Aurelio
    Cervera, Ricard
    [J]. CLINICAL RHEUMATOLOGY, 2008, 27 (07) : 891 - 897